Led by the Gamaleya Epidemiology and Microbiology Research Center, which has over 40 years of experience in adenoviral vectors, production processes of the first adenovector-based COVID-19 vaccine were initiated in Turkey.
In the field of biotechnology, by establishing business partnerships in international markets for Viscoran-identified innovative products, we carry out post-technology transfer production, sales-marketing, import and export activities.
GET INFOIn order to obtain local efficacy and safety data in the drug / medical product development process, Viscoran conducts clinical research in Turkey.
REVIEWJoint marketing and licensing agreements are agreed upon in order to enhance the product range with innovative and advanced technology products.
REVIEWCOVID-19 vaccine based on human Adenovirus vectors, pioneered by Viscoran in Turkey; It is a platform developed by the Russian Gamaleya Epidemiology and Microbiology Research Center and has been studied since the 1980s.
DISCOVER MOREBiotechnology is a multidisciplinary branch of science and technology that uses living organisms or systems to obtain useful products, improving the quality of human life and furthering product development as a result of the interactions between biological sciences and technology, such as biology, biochemistry, microbiology.
ReviewPartner In Turkey
We respond to changing needs with innovative products.